The 90 page report “Booming Biotech Market in India is available at http://www.piribo.com/
The report provides an exhaustive overview of the biotechnology market in India. It provides a detailed account of the factors that define the structure and composition of the Indian biotechnology market, making it one of the world's most potential markets.
Key Findings from the report include:
The Indian biotechnology market, valued at INR 112.6 Billion (US$ 2.86 Billion) in 2007-08, is projected to hit a CAGR of 30% in near future.
Exports presently dominate the Indian biotechnology market, with bioservices and bioinformatics in particular being export driven industries.
Biopharma remains India's biggest sector accounting for nearly 70% of the total revenues in 2007-08. By 2012-13, the sector is expected to be worth INR 224.13 Billion (US$ 5.7 Billion).
The bioagriculture sector, driven by the sales of BT cotton, is the industry's fastest growing sector. Commercial approval of more transgenic plants is likely to push further growth in this sector.
Strong R&D capability and a large patient pool for clinical trials are expected to make the bioservices sector amongst the most potential sectors in the Indian biotechnology market.
Filliped by the surge in both R&D and production, the future of the biosupplier industry looks bright.
The research findings help identify the difference between the biotechnology market in India and the US and European markets in terms of factors like structure and composition, R&D, level of commercialization, and association between industry and academia that make India a preferred destination. Thus, it provides valuable information to pharmaceutical/
“Booming Biotech Market in India” is available in pdf format from Piribo.
For more information, go to: http://www.piribo.com/
Piribo product ID: RCS300
About Piribo.
Piribo (http://www.piribo.com/
